Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® (Tenecteplase) in Korean Patients With Acute Myocardial Infarction

NCT02206646 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02206646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02206646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® (Tenecteplase) in Korean Patients With Acute Myocardial Infarction
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
February 28, 2003
Completion date
Not reported
Enrollment
987 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction